GoodRx, founded in 2011, operates with the mission encapsulated in their slogan: "We believe everyone deserves affordable, convenient healthcare." The company has positioned itself as a leader in making prescription pricing transparent, boldly claiming to have saved consumers over $85 billion on both brand name and generic medications, regardless of insurance coverage.
Headquartered in the United States, GoodRx extends its services nationally, offering free prescription savings, trustworthy health information, and affordable subscription plans. The company remains steadfast in its commitment to enhancing healthcare accessibility.
The company's notable achievement includes a last investment milestone, a substantial $1.14B raised during their IPO on 01 September 2020. This significant capital infusion underscores market confidence in GoodRx's business model and growth potential. Investors evaluating this company will find an established healthcare disruptor with a clear, impactful mission and a proven track record in cost savings.